Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Inventory (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Inventory for 16 consecutive years, with $70.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 8.46% to $70.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.4 million, a 8.46% increase, with the full-year FY2025 number at $70.4 million, up 8.46% from a year prior.
  • Inventory was $70.4 million for Q4 2025 at Lemaitre Vascular, down from $70.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $70.8 million in Q3 2025 to a low of $44.3 million in Q3 2021.
  • A 5-year average of $56.2 million and a median of $55.0 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: decreased 3.43% in 2021, then grew 18.28% in 2024.
  • Lemaitre Vascular's Inventory stood at $46.1 million in 2021, then increased by 9.04% to $50.3 million in 2022, then rose by 15.53% to $58.1 million in 2023, then rose by 11.79% to $64.9 million in 2024, then increased by 8.46% to $70.4 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Inventory are $70.4 million (Q4 2025), $70.8 million (Q3 2025), and $68.4 million (Q2 2025).